Back to top

Image: Shutterstock

Top Ranked Value Stocks to Buy for July 9th

Read MoreHide Full Article

Here are four stocks with buy rank and strong value characteristics for investors to consider today, July 9th:

Northrim BanCorp, Inc. (NRIM - Free Report) : This bank holding company for Northrim Bank has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 21.4% over the last 60 days.

 

Northrim BanCorp has a price-to-earnings ratio (P/E) of 7.78, compared with 12.70 for the industry. The company possesses a Value Score of A.

 

Northrim BanCorp Inc PE Ratio (TTM)

Northrim BanCorp Inc PE Ratio (TTM)

Northrim BanCorp Inc pe-ratio-ttm | Northrim BanCorp Inc Quote

 

Group 1 Automotive, Inc. (GPI - Free Report) : This company that through its subsidiaries, operates in the automotive retail industry has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 9.4% over the last 60 days.

 

Group 1 Automotive has a price-to-earnings ratio (P/E) of 7.68, compared with 11.40 for the industry. The company possesses a Value Score of A.

 

Winnebago Industries, Inc. (WGO - Free Report) : This leading manufacturer of recreation vehicles has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 5.6% over the last 60 days.

 

Winnebago Industries has a price-to-earnings ratio (P/E) of 8.42, compared with 15.90 for the industry. The company possesses a Value Score of B.

 

Westlake Chemical Corporation (WLK - Free Report) : This vertically integrated international manufacturer and supplier of petrochemicals, polymers and fabricated products has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 25.5% over the last 60 days.

 

Westlake Chemical has a price-to-earnings ratio (P/E) of 7.80, compared with 14.50 for the industry. The company possesses a Value Score of A.

 

See the full list of top ranked stocks here.

Learn more about the Value score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Published in